Curcumin-Piperine Supplementation in STEMI - SPICE STEMI Trial

计划入组 50 人 · 首次发布于 2025 年 9 月 2 日

Impact of Cardio-Selective Beta-Blockers on Infarct Size After Acute Myocardial Infarction

计划入组 100 人 · 首次发布于 2025 年 12 月 19 日

TIRANA-ACS: A Prospective Registry Study for the Targeted Investigation of Residual Inflammation After Non-ST/ ST Elevation Acute Coronary Syndrome

计划入组 1,600 人 · 首次发布于 2025 年 6 月 18 日

Stearic acid

C₁₈H₃₆O₂

STS inhibitor(Sterix)

StetriX, Inc.

United States

Steri-Pharma, LLC

United States

STERIL-GENE LIFE SCIENCES PRIVATE LIMITED

India

StemRIM Expands Global Patent Portfolio for Redasemtide Cartilage Regeneration Therapy

Redasemtide Clears Ulcer Endpoint in Dystrophic EB but Misses Primary Endpoint in Global Phase 2 Acute Ischemic Stroke Trial

CeleCor's Zalunfiban Meets Primary Endpoints in Phase III STEMI Trial